Sinovac Biotech Ltd. | Small-cap
$6.47
0.00%
| Sinovac Biotech Stock Comparison:
Sinovac Biotech vs VishaySinovac Biotech vs Weis MarketsSinovac Biotech vs American NationalSinovac Biotech vs UpworkSinovac Biotech vs Dream Finders HomesSinovac Biotech vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2023

Income Metrics

Revenue 448.3M
Gross Profit 266.8M 59.51%
Operating Income -524.3M -116.96%
Net Income -258.4M -57.63%
EPS (Diluted) -$1.06

Balance Sheet Metrics

Total Assets 13.7B
Total Liabilities 1.6B
Shareholders Equity 12.0B
Debt to Equity 0.14

Cash Flow Metrics

Operating Cash Flow 113.6M
Free Cash Flow -41.7M

Revenue & Profitability Trend

Sinovac Biotech Income Statement From 2019 to 2023

Metric 2023 2022 2021 2020 2019
Revenue 448.3M 1.5B 19.4B 510.6M 246.1M
Cost of Goods Sold 181.5M 684.5M 1.1B 67.2M 32.5M
Gross Profit 266.8M 808.3M 18.3B 443.4M 213.6M
Operating Expenses 788.4M 1.3B 745.5M 225.0M 145.0M
Operating Income -524.3M -460.9M 17.6B 215.8M 68.9M
Pre-tax Income -153.0M 25.2M 17.6B 216.6M 70.8M
Income Tax 105.3M -62.9M 3.1B 31.4M 5.6M
Net Income -258.4M 88.1M 14.5B 185.2M 65.2M
EPS (Diluted) -$1.06 $1.00 $74.27 $0.97 $0.41

Income Statement Trend

Sinovac Biotech Balance Sheet From 2019 to 2023

Metric 2023 2022 2021 2020 2019
Assets
Current Assets 11.8B 12.1B 14.9B 1.6B 349.6M
Non-Current Assets 1.8B 2.0B 1.8B 341.0M 102.7M
Total Assets 13.7B 14.1B 16.7B 1.9B 452.3M
Liabilities
Current Liabilities 1.1B 1.1B 2.4B 679.6M 87.2M
Non-Current Liabilities 487.3M 310.3M 459.3M 101.6M 12.9M
Total Liabilities 1.6B 1.4B 2.9B 781.2M 100.1M
Equity
Total Shareholders Equity 12.0B 12.7B 13.9B 1.1B 352.2M

Balance Sheet Composition

Sinovac Biotech Cash Flow Statement From 2019 to 2023

Metric 2023 2022 2021 2020 2019
Operating Activities
Net Income -258.4M 88.1M 14.5B 185.2M 65.2M
Operating Cash Flow 113.6M 332.5M 14.2B 483.8M 30.9M
Investing Activities
Capital Expenditures -144.5M -393.2M -719.7M -127.5M -10.6M
Investing Cash Flow -2.9B -5.8B -3.0B -204.6M -42.5M
Financing Activities
Dividends Paid -328.1M -263.2M -1.9B 0 0
Financing Cash Flow -76.1M -241.4M -1.9B 592.6M 1.7M
Free Cash Flow -41.7M -1.2B 14.6B 351.7M 28.4M

Cash Flow Trend

Sinovac Biotech Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 6.66
Forward P/E -53.92
Price to Book 0.05
Price to Sales 1.43
PEG Ratio -53.92

Profitability Ratios

Profit Margin 59.51%
Operating Margin -33.63%
Return on Equity -0.88%
Return on Assets -0.78%

Financial Health

Current Ratio 10.31
Debt to Equity 0.02

Per Share Data

EPS (TTM) -$1.06
Book Value per Share $121.57
Revenue per Share $4.50

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
sva 642.4M 6.66 0.05 -0.88% 59.51% 0.02
Vishay 2.1B 26.84 1.03 -3.10% -2.28% 54.50
Weis Markets 2.0B 18.56 1.37 7.54% 2.23% 11.56
American National 2.0B - 0.67 5.04% 3.74% 31.41
Upwork 1.7B 8.01 3.00 49.80% 30.46% 62.32
Dream Finders Homes 2.1B 6.71 1.62 25.92% 7.28% 101.85

Financial data is updated regularly. All figures are in the company's reporting currency.